Arthur Bregman, MD
Psychiatry · Coral Gables, FLNPI 1538102397
Payments from drug & device makers
Across 272 payments — averaging $16.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$1K
- AbbVie$744
- Sunovion Pharmaceuticals Inc.$706
- Shire North American Group Inc$330
- Otsuka America Pharmaceutical, Inc.$325
- Lundbeck LLC$301
- plus $779 from 12 others
What the payments were for
- Food & beverage$4,485100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 70 | $1,300 |
| AbbVie(2 entities) | 62 | $744 |
| Sunovion Pharmaceuticals Inc. | 35 | $706 |
| Shire North American Group Inc | 23 | $330 |
| Otsuka America Pharmaceutical, Inc. | 17 | $325 |
| Lundbeck LLC | 19 | $301 |
| Neos Therapeutics, LP | 12 | $203 |
| Ironshore Pharmaceuticals Inc. | 14 | $171 |
| Vanda Pharmaceuticals Inc. | 4 | $98 |
| Supernus Pharmaceuticals, Inc. | 3 | $60 |
| Corium, LLC | 3 | $56 |
| Tris Pharma Inc | 2 | $40 |
| Vertical Pharmaceuticals, LLC | 2 | $36 |
| Johnson & Johnson | 2 | $31 |
| Axsome Therapeutics, Inc. | 1 | $26 |
| Jazz Pharmaceuticals Inc. | 1 | $24 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $20 |
| Adlon Therapeutics L.p. | 1 | $16 |
How this compares
$4,485 in reported general payments places this provider in the 80th percentile of 2,059 psychiatry providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 57 | $4,187 |
| Bupropion XlBupropion Hcl | 74 | $2,950 |
| Haloperidol | 32 | $2,773 |
| Fluvoxamine Maleate | 30 | $2,689 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 70 | $1,931 |
| Trazodone Hcl | 73 | $1,547 |
| Quetiapine Fumarate | 71 | $1,524 |
| Risperidone | 69 | $1,486 |
| Divalproex Sodium | 26 | $1,208 |
| Guanfacine Hcl ErGuanfacine Hcl | 20 | $1,015 |
| Benztropine Mesylate | 64 | $838 |
| Fluoxetine Hcl | 37 | $498 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 12 | $454 |
| Olanzapine | 26 | $418 |
| Alprazolam | 91 | $343 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Coral Gables
- Moraima TrujilloCoral Gables$6.6M
- Ilan MelnickCoral Gables$2.8M
- Yesenia KuanCoral Gables$2.1M
- Evelyn Lopez-BrignoniCoral Gables$2M
- Edwin GomezWeston$24.9M
- Rishi KakarTamarac$23.9M
- Peter VentreOakland Park$18.7M
- Jose GamezHialeah$14.8M
- John JoyceJacksonville$13.6M
- Silvia Silva-DulucMiami$11.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.